![]() |
市場調查報告書
商品編碼
2048416
基因改造生物食品安全檢測市場-全球產業規模、佔有率、趨勢、機會、預測:按食品類型、地區和競爭格局分類,2021-2031年Genetically Modified Food Safety Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Food Type (Crops, Processed Foods, Others), By Region & Competition, 2021-2031F |
||||||
全球基因改造食品安全檢測市場預計將從 2025 年的 30.2 億美元成長到 2031 年的 47.5 億美元,複合年成長率為 7.84%。
該市場涵蓋必要的分析和檢驗流程,以確保基因改造農產品在進入供應鏈之前符合嚴格的健康和環境標準。該市場的成長主要受全球生物技術作物種植擴張和日益成長的糧食安全需求的驅動。因此,嚴格遵守國際貿易法規對於防止供應鏈中斷至關重要。例如,國際農業生物技術應用與獲取服務組織(ISAAA)報告稱,到2025年,全球用於種植、食品和飼料用途的基因改造作物核准數量將達到534個,這凸顯了安全評估檢驗的必要性。然而,一個主要挑戰是不同司法管轄區法規缺乏統一性。這導致核准時間和對低水平基因改造生物污染的容忍度各不相同,可能使貿易複雜化,增加合規成本,並延緩新生物技術品種的引進。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 30.2億美元 |
| 市場規模:2031年 | 47.5億美元 |
| 複合年成長率:2026-2031年 | 7.84% |
| 成長最快的細分市場 | 農作物 |
| 最大的市場 | 北美洲 |
市場的主要促進因素是嚴格的全球法規結構和強制性標籤要求的引入。這迫使出口商採取嚴格的篩檢程序,以應對複雜的國際合規性。在對核准的生物技術產品實施零容忍政策和嚴格標籤標準的國家,對旨在防止邊境扣押和貿易爭端的全面檢驗流程的需求日益成長。不斷增加的工作量也反映在安全警報數量的上升上。根據Merew NutriScience報告,2025年3月,透過食品和飼料快速預警系統(RASFF)收到的警報數量增加了8%,達到4695條。為了加強監管執法,各國政府正積極投資提升分析能力。例如,2025年1月,英國食品標準局(FSA)撥款120萬英鎊給17個國家標準實驗室,用於維護和提升國內檢測能力。基因改造作物商業化種植的顯著擴張進一步加劇了對嚴格安全檢測的需求,因為這增加了全球供應鏈中生物技術產品的數量。基因改造作物在主要農業區的廣泛應用增加了污染風險,因此需要頻繁檢測以驗證其非基因改造狀態,並確保其性狀純度,以滿足維持原有特性的市場需求。美國農業部2025年6月的統計數據顯示,美國94%的玉米種植面積將為生物技術品種,這凸顯了該市場的主導地位,也表明這些作物的普遍性以及對高通量診斷解決方案的需求,以確保對基因改造成分的控制和符合安全標準。
由於不同國際司法管轄區的監管環境分散,全球基因改造食品安全檢測市場面臨許多挑戰。缺乏監管協調迫使檢測實驗室和出口商應對不一致的核准時間表和不同的基因改造生物容許閾值。當一項生物技術性狀在一個國家核准,而在另一個國家核准批准時,就需要開發和應用多種不同的分析方案,以滿足每個市場特定的零容忍或低含量政策。這種監管複雜性直接阻礙了市場擴張,增加了與安全檢驗相關的營運成本和技術負擔,並可能使小規模企業望而卻步,從而阻礙其參與國際貿易。因此,這些廣泛的合規要求延長了新型農業生物技術產品的商業化進程,並減少了需要進行檢測的新品種進入供應鏈的數量。正如國際作物生命組織(CropLife International)在2024年發布的報告所述,這些監管瓶頸的影響是巨大的。嚴格且多變的全球法規環境導致將新的生物技術植物性狀推向市場的平均研發時間約為16年,成本接近1.15億美元。這種漫長的研發過程阻礙了對新產品研發的投資,最終抑制了對相關安全測試服務的需求,限制了市場的潛在成長。
目前,市場正顯著轉向外包第三方檢測服務。這主要是由於維護諸如次世代定序(NGS) 和數位 PCR 等先進診斷能力需要大量的資本投入。隨著建造最先進的內部檢測設施的財務負擔日益加重,中小食品生產商擴大使用經認證的參考實驗室來確保符合複雜的全球法規。這種產業整合體現在主要服務供應商的擴張上。例如,梅里埃營養科學公司在 2025 年 9 月收購必維國際檢驗集團 (Bureau Veritas) 的食品檢測業務後,將其全球網路擴展至 140 多家經認證的實驗室。同時,能夠實現供應鏈早期階段即時決策的現場快速檢測設備也日益普及。相關人員不再依賴中心實驗室進行初步篩檢,而是傾向於使用可攜式解決方案,例如側向層析檢測套組和行動 PCR 設備,這些設備使農民和糧食倉儲設施能夠在現場驗證作物純度。市場對這些分散式檢查解決方案的需求日益成長,這體現在市場領導者的表現上。 NeoGen公司公佈2025年1月快報季度以金額為準為2.313億美元。該公司將這一成功歸功於其食品安全領域核心收入來源的加速成長。
The Global Genetically Modified Food Safety Testing Market is projected to expand from USD 3.02 billion in 2025 to USD 4.75 billion by 2031, at a compound annual growth rate (CAGR) of 7.84%. This market encompasses the analytical and verification processes crucial for ensuring genetically engineered agricultural products meet rigorous health and environmental standards before entering the supply chain. Its growth is primarily fueled by the increasing global cultivation of biotech crops and the intensifying demand for food security, which necessitates strict adherence to international trade regulations to prevent supply chain disruptions. For instance, in 2025, the International Service for the Acquisition of Agri-biotech Applications reported 534 global approvals for genetically modified crops across cultivation, food, and feed uses, underscoring the vital need for validated safety assessments. A significant challenge, however, is the lack of regulatory harmonization across different jurisdictions, leading to varied approval timelines and tolerance levels for low-level GMO presence, which complicates trade, escalates compliance costs, and can delay the commercial introduction of new biotech varieties.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.02 Billion |
| Market Size 2031 | USD 4.75 Billion |
| CAGR 2026-2031 | 7.84% |
| Fastest Growing Segment | Crops |
| Largest Market | North America |
Market Driver
A primary catalyst for the market is the implementation of stringent global regulatory frameworks and mandatory labeling requirements, which compel exporters to adopt rigorous screening protocols to navigate complex international compliance landscapes. Nations enforcing zero-tolerance policies or strict labeling thresholds for unapproved biotech events intensify the demand for comprehensive verification processes, aiming to prevent border rejections and trade disputes. This growing operational burden is reflected in rising safety alerts, with the Rapid Alert System for Food and Feed recording an 8% increase to 4,695 notifications in March 2025, as per Merieux NutriSciences. To bolster enforcement, governments are actively funding analytical capabilities; for example, the Food Standards Agency allocated £1.2 million across 17 National Reference Laboratory areas in January 2025 to maintain and enhance national testing proficiency. Further accelerating the necessity for robust safety testing is the substantial expansion in the commercial cultivation of genetically modified crops, which increases the volume of biotech commodities in the global supply chain. The widespread adoption of engineered varieties in key agricultural regions elevates the risk of commingling, requiring frequent checks to verify non-GMO status or confirm trait purity for identity-preserved markets. This market dominance is evident from USDA statistics in June 2025, showing 94% of all U.S. corn acres were biotech varieties, highlighting the ubiquity of these crops and the consequent need for high-throughput diagnostic solutions to manage genetically modified ingredients and ensure compliance with safety standards.
Market Challenge
The Global Genetically Modified Food Safety Testing Market faces a considerable impediment due to the fragmented regulatory landscape across various international jurisdictions. This absence of harmonized regulations forces testing laboratories and exporters to contend with asynchronous approval timelines and differing tolerance thresholds for genetically modified organisms. When a biotech trait receives approval in one country but not another, it mandates the development and application of multiple, distinct analytical protocols to satisfy each market's specific zero-tolerance or low-level presence policies. This regulatory complexity directly hinders market expansion by increasing the operational costs and technical burdens associated with safety verification, potentially discouraging smaller entities from participating in international trade. Consequently, these extensive compliance demands prolong the commercialization process for new agricultural biotechnology products, thereby decreasing the volume of novel varieties entering the supply chain that would require testing. The impact of these regulatory bottlenecks is substantial, as reported by CropLife International in 2024, where rigorous and disparate global regulatory environments contributed to an average development period of approximately 16 years and a cost of nearly USD 115 million to introduce a new biotech plant trait to market. Such protracted timelines deter investment in new product development, ultimately stagnating the demand for associated safety testing services and limiting the market's potential growth.
Market Trends
The market is currently undergoing a notable shift towards outsourced third-party testing services, primarily spurred by the high capital expenditures required to maintain advanced diagnostic capabilities, such as Next-Generation Sequencing and digital PCR. As the financial burden of establishing state-of-the-art in-house facilities escalates, smaller and mid-sized food manufacturers are increasingly engaging accredited reference laboratories to ensure adherence to complex global regulations. This industry consolidation is exemplified by the operational expansion of key service providers; for instance, Merieux NutriSciences expanded its global network to over 140 accredited laboratories following its acquisition of Bureau Veritas' Food Testing Business in September 2025. Simultaneously, there is a widespread proliferation of rapid point-of-need testing devices, which enable immediate decision-making earlier in the supply chain. Stakeholders are moving away from an exclusive reliance on central laboratories for initial screening, instead favoring portable solutions like lateral flow devices and mobile PCR units that allow farmers and grain elevators to verify crop purity on-site. This growing demand for decentralized testing solutions is reflected in the financial performance of market leaders, with Neogen Corporation reporting preliminary quarterly revenues of USD 231.3 million in January 2025, attributing this success to accelerating core revenue growth within its Food Safety segment.
Report Scope
In this report, the Global Genetically Modified Food Safety Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Genetically Modified Food Safety Testing Market.
Global Genetically Modified Food Safety Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: